Thursday, July 9, 2026

biotech · LSBCF

LakeShore Biopharma Co

LakeShore Biopharma Co drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

DAXING DISTRICT, BEIJING, F4, USA HQ
Public company Type
LSBCF · NYSE Ticker
Company details
Status
Public
HQ
DAXING DISTRICT, BEIJING, F4, USA
Programs
0
Drugs
0
Patents
0
Intelligence · Drug Pipeline

LakeShore Biopharma Co pipeline

Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.

LakeShore Biopharma Co drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.

No drugs indexed yet

We have not linked approved or pipeline drugs to this company profile yet.

View clinical projects →